0

Neuromodulation Market Expected to Reach $4.3 Billion by 2030

 
2022
Neuromodulation Market

Report Code : A01167

quote Alarming rise in prevalence of neurological disorder, rise in number of hospitals, and advancement in technology for neuromodulation devices are expected to notably contribute toward the growth of the global neuromodulation market during the forecast period. quote

Onkar Sumant - Manager
Life Sciences at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, Neuromodulation Market," The neuromodulation market size was valued at $2,480.21 million in 2020, and is estimated to reach $4.3 Billion by 2030, growing at a CAGR of 6.2% from 2021 to 2030. Neuromodulation devices stimulate nerves with pharmaceutical agents, electrical signals, or other forms of energy by modulating abnormal neural pathway behavior caused by the disease process. Neuromodulation devices include, deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus nerve stimulation (VNS), and spinal cord stimulation (SCS). These neuromodulation devices are used in treatment of neurological disorders, such as epilepsy, tremor, urinary and fecal incontinence, depression, and dystonia.

Factors that drive the growth of the neuromodulation market trends include, the rise in number of hospitals, increase in prevalence of neurological diseases, and rise in number of geriatric population. According to the Journal of Aging in the United States, in July 2019, it was reported that a number of Americans aged 65 and older, is projected to increase more than double from 52 million in 2018 to over 95 million by 2060, and is expected to rise to around 23% from 16%. Furthermore, increase in R&D activities in the healthcare sector and new product launch of neuromodulation devices contribute in the neuromodulation market growth. For instance, in July 2021, Nevro Corporation, a medical device company, received FDA approval for its 10 kHz high frequency spinal cord stimulation therapy for the treatment of chronic pain associated with painful diabetic neuropathy (PDN).

The neuromodulation market is segmented on the basis of technology, application, biomaterial, and region. By technology, the market is divided into internal neuromodulation and external neuromodulation. The internal neuromodulation segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to the advancement in deep brain stimulation (DBS) systems.

On the basis of application, the market is categorized into chronic pain, urinary and fecal incontinence, migraine, failed back syndrome, Parkinson disease, epilepsy, tremor, depression, and other applications. The chronic pain segment dominated the market in 2020, and this trend is expected to continue during the forecast period, owing to increase in prevalence of chronic disorder and increase in R&D activities in the pharmaceutical sector.

By biomaterial, the market is divided into metallic biomaterials, polymeric biomaterials, and ceramic biomaterials. The metallic biomaterials segment dominated the market in 2020, and this trend is expected to continue during the forecast period, due to advantages of metallic biomaterials.

North America accounted for a majority of the global neuromodulation market share in 2020, and is anticipated to remain dominant during the forecast period, due to the rise in prevalence of neurological diseases, presence of key players for development of neuromodulation devices, and well-established infrastructure in the region. Asia-Pacific is anticipated to witness lucrative growth of neuromodulation Industry, owing to an increase in the number of hospitals, prevalence of epilepsy and high geriatric population.

The COVID-19 outbreak is anticipated to have a negative impact on the growth of the neuromodulation market as most hospitals are not operating due to the ongoing lockdowns in many countries. The spread of COVID-19 led to a major public health issue. However, a huge number of clinics and hospitals across the globe were restructured to increase the hospital capacity to provide better healthcare facility. According to the Livanova, a medical technology company, it was reported that the neuromodulation sale decrease due to decline in both new patient and service implant procedure, across the globe.

 

KEY FINDINGS OF STUDY

  • On the basis of technology, the internal neuromodulation segment was the highest contributor to the market in 2020.
  • On the basis of application, the chronic pain segment was the highest contributor to the market in 2020
  • Depending on biomaterial, metallic biomaterials segment dominated the market in 2020.

•    On the basis of region, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

 

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
 
 

First time buyer?
Check offers and discount on this report
To get this report

Click Here
 
 

quote Neuromodulation Market by Technology (Internal Neuromodulation, External Neuromodulation), by Application (Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications), by Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials), : Global Opportunity Analysis and Industry Forecast, 2020-2030 quote

View Report
 
 

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 2,000 niche industries and company profiles on more than 12,000 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

WHY ALLIED MARKET RESEARCH?

INFLALLIBLE METHODOLOGY

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

ANALYST SUPPORT

For complete satisfaction

CUSTOMIZATION

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date Mar 2024

Dithiocarbamate Market

Download Sample
rep-img

Published Date Mar 2024

Hedge Fund Market

Download Sample
rep-img

Published Date Mar 2024

Family Office Market

Download Sample

Buy Full Version
"Neuromodulation Market"
Purchase Enquiry

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of the scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save the time of readers